Background: Benign prostate hypertrophy (BPH) is mainly characterized by the increase in volume of the prostate gland. It is a frequently encountered pathology in current urological practice. The aim of the study was to evaluate various aspects of the management of postoperative complications, after BPH surgery, in a subsaharan nation. Methodology: This was a retrospective descriptive study carried out at the Douala General Hospital (DGH) and Douala Laquintinie Hospital (DLH) over a period of 5 years (January 1st 2016 to December 31st 2020). The results were compiled from (1st February to 31st May 2021) and data analysed using SPSS 25.0. The confidence interval was set at 95% where a p-value of less than 0.05 was considered statistically significant. Results: There were 151 cases in this study. The mean age was 72.3±11.8 years. Majority of the patients were within 60-69 years (27.83%). Pollakiuria, Nocturia and dysuria were the most common reasons of consultation. The medical management of BPH included alpha-blockers (55%), five alpha-reductase inhibitors (10.6%), phytotherapy (13.2%), and combination therapy (15.9%). With respect to surgical management open simple prostatectomy (OSP) was done in 65.6% of patients and Transurethral Resection of Prostate (TURP) in 34.4%. The rate of intraoperative complications was 15.9%, predominantly hemorrhage at 6.6%. Immediate and early complications acounted for 56% of complications with urinary tract infections making up the majority (22.5%). Late complications accounted for 28.8%. The incidence of intraoperative and late postoperative complications was associated with the type of surgery. This association was statistically significant with p-value of 0.013 and 0.030 for introperative and late complications respectively. The average duration of hospitalisation was 9.69± 3.053days. Conclusion: BPH is common in our setting among men older than 50 years. OSP and TURP are the surgical techniques mostly done in our setting. Hemorrhage, UTI and persistence of pollakiuria were the most common complications of BPH surgeries.
| Published in | International Journal of Clinical Urology (Volume 9, Issue 1) |
| DOI | 10.11648/j.ijcu.20250901.26 |
| Page(s) | 94-100 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2025. Published by Science Publishing Group |
BPH, Postoperative Complications, Management, Sub-Saharan, Aspects
| [1] | Adakal O, Rouga MM, Abdoulaye MB, Adamou H, Maikassoua M, Mounkeila I, James Didier L, Magagi IA, Roua A, Halidou M2, Habou O, Sani R. Benign prostate hypertrophy at the Maradi Regional Hospital Center: clinical presentation, treatment and outcome. The journal of medicine and biomedical sciences. 2021; 22 (11): 93-97. |
| [2] | Ofoha CG, Raphael JE, Dakum NK, Shu'aibu SI, Akhaine J, Yaki IM. Surgical management of benign prostate hyperplasia in Nigeria: open prostatectomy versus transurethral resection of the prostate. Pan Afr Med J. 2021; 39: 165. |
| [3] | Parsons JK. Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep. 2010; 5(4): 212–218. |
| [4] | Zubair A, Davis S, Balogun DI, Nwokeocha E, Chiedozie CA, Jesuyajolu D. A Scoping Review of the Management of Benign Prostate Hyperplasia in Africa. Cureus. 2022; 14(11): e31135. |
| [5] | Olapade EO, Olapade EO Jr., Olapade CO, Olapade OC. Phytomedicines for the treatment of benign prostatic hyperplasia without surgery in Nigeria. Acta Hortic. 2003; 597: 231–234. |
| [6] | Ogbonna BC, Okeahialam BN, Ramyil VM. Alpha-receptor blockade for benign prostatic hyperplasia: uses and problems in a developing country. Br J Urol. 1997; 79: 32–35. |
| [7] | Ahmed Gadam I, Nuhu A, Aliyu S. Ten-year experience with open prostatectomy in maiduguri. ISRN Urol. 2012; 2012: 406872. |
| [8] | Salako AA, Badmus TA, Owojuyigbe AM, David R, Ndegbu C, Onyeze C. Open prostatectomy in the management of benign prostate hyperplasia in a developing economy. Open J Urol. 2016; 6: 179–189. |
| [9] | Elshal AM, Mekkawy R, Laymon M, Barakat TS, Elsaadany MM, El-Assmy A, El-Nahas AR. Holmium laser enucleation of the prostate for treatment for large-sized benign prostate hyperplasia; is it a realistic endourologic alternative in developing country? World J Urol. 2016; 34: 399–405. |
| [10] | Ondongo A A. M, Ondziel O A. S., Dimi N Y., Banga M R. B., Okamba S., Service M., Odzébé A. W. S., Bouya P. A. Management of benign prostatic hyperplasia at the Brazzaville Hospital and University Center. Uro’andro. 2020; 2(4): 138-143. |
| [11] | Rimtebaye K., Mpah E., Tashkand A., Sillong F., Kaboro M., Niang, L. and Gueye, S. (2017) Epidemiological, Clinical and Management of Benign Prostatic Hypertrophia in Urologie Department in N’Djamena, Chad. Open Journal of Urology, 7, 9-15. |
| [12] | Fall P. A., Gueye, S. M., Ndoye, A. K., Diao, D., Thiam, O. B. K., Abdallahi, M. O. C., et al. (2002) Mortalité et Morbidité précoces après adénomectomie prostatique par voie transvésicale. African Journal of Urology, 8, 20-23. |
| [13] | Alhasan SU, Aji SA, Mohammed AZ, Malami S. Transurethral resection of the prostate in Northern Nigeria, problems and prospects. BMC Urol. 2008; 8: 18. |
| [14] | Manfredi M, Fiori C, Peretti D, Piramide F, Checcucci E, Garrou D, Amparore D, De Luca S, Di Dio M, Scarpa RM, and Porpiglia, F. Laparoscopic simple prostatectomy: complications and functional results after five years of follow-up. Minerva Urol Nefrol. 2020; 72(4): 498-504. |
| [15] | Fouda PJ, Moby Mpay E, Mekeme Mekeme J, Angwafor F, Sow M. La Symptomatologie du Bas Appareil Urinaire de l’Homme à l’Hôpital Central de Yaoundé. À Propos de 329 Cas. Health Sci. Dis. 2013; 14(3). |
| [16] | Bagayogo NA, Sine B, Faye M, Sarr A, Thiam A, Ndiaye M, Ndiath A, Ndour NS, Traoré A, Erradja F, Faye ST, Sow Y, Fall B, Diao B, Ndoye AK, Ba M. Hypertrophie bénigne de la prostate (HBP) géante: Aspects épidémiologiques, cliniques et thérapeutiques. Journal Africain d’Urologie. 2021; 27(1): 49-55. |
| [17] | Bishr M, Boehm K, Trudeau V, Tian Z, Dell'Oglio P, Schiffmann J, Jeldres C, Sun M, Shariat SF, Graefen M, Saad F, Karakiewicz PI. Medical management of benign prostatic hyperplasia: results from a population-based study. Can Urol Assoc J. 2016; 10: 55–59. |
| [18] | Kane R, Ndiaye A, and Ogougbemy M. Résection transurétrale de prostate. Expérience de l’Hôpital Principal de Dakar, Sénégal. Méd Afr Noire. 2013; 60(3): 110-114. |
| [19] | Salako AA, Badmus TA, Owojuyigbe AM, David R, Ndegbu C, Onyeze C. Open prostatectomy in the management of benign prostate hyperplasia in a developing economy. Open J Urol. 2016; 6: 179–189. |
| [20] | Pariser JJ, Pearce SM, Patel SG, Bales GT. National Trends of Simple Prostatectomy for Benign Prostatic Hyperplasia with an Analysis of Risk Factors for Adverse Perioperative Outcomes. Urology. 2015; 86(4): 721-725. |
APA Style
Guy, E. N. F., Quentin, E. A., Oriole, M. L., Thérèse, M. F. V., Aurel, M. A., et al. (2025). Sub-Saharan Aspects for the Benign Prostate Hypertrophy Postoperative Complications. International Journal of Clinical Urology, 9(1), 94-100. https://doi.org/10.11648/j.ijcu.20250901.26
ACS Style
Guy, E. N. F.; Quentin, E. A.; Oriole, M. L.; Thérèse, M. F. V.; Aurel, M. A., et al. Sub-Saharan Aspects for the Benign Prostate Hypertrophy Postoperative Complications. Int. J. Clin. Urol. 2025, 9(1), 94-100. doi: 10.11648/j.ijcu.20250901.26
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijcu.20250901.26,
author = {Epoupa Ngalle Frantz Guy and Essomba Armel Quentin and Mbouché Landry Oriole and Mokam Fotso Victoire Thérèse and Mbassi Achille Aurel and Moby Mpah Hervé Edouard and Fouda Pierre Joseph},
title = {Sub-Saharan Aspects for the Benign Prostate Hypertrophy Postoperative Complications
},
journal = {International Journal of Clinical Urology},
volume = {9},
number = {1},
pages = {94-100},
doi = {10.11648/j.ijcu.20250901.26},
url = {https://doi.org/10.11648/j.ijcu.20250901.26},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcu.20250901.26},
abstract = {Background: Benign prostate hypertrophy (BPH) is mainly characterized by the increase in volume of the prostate gland. It is a frequently encountered pathology in current urological practice. The aim of the study was to evaluate various aspects of the management of postoperative complications, after BPH surgery, in a subsaharan nation. Methodology: This was a retrospective descriptive study carried out at the Douala General Hospital (DGH) and Douala Laquintinie Hospital (DLH) over a period of 5 years (January 1st 2016 to December 31st 2020). The results were compiled from (1st February to 31st May 2021) and data analysed using SPSS 25.0. The confidence interval was set at 95% where a p-value of less than 0.05 was considered statistically significant. Results: There were 151 cases in this study. The mean age was 72.3±11.8 years. Majority of the patients were within 60-69 years (27.83%). Pollakiuria, Nocturia and dysuria were the most common reasons of consultation. The medical management of BPH included alpha-blockers (55%), five alpha-reductase inhibitors (10.6%), phytotherapy (13.2%), and combination therapy (15.9%). With respect to surgical management open simple prostatectomy (OSP) was done in 65.6% of patients and Transurethral Resection of Prostate (TURP) in 34.4%. The rate of intraoperative complications was 15.9%, predominantly hemorrhage at 6.6%. Immediate and early complications acounted for 56% of complications with urinary tract infections making up the majority (22.5%). Late complications accounted for 28.8%. The incidence of intraoperative and late postoperative complications was associated with the type of surgery. This association was statistically significant with p-value of 0.013 and 0.030 for introperative and late complications respectively. The average duration of hospitalisation was 9.69± 3.053days. Conclusion: BPH is common in our setting among men older than 50 years. OSP and TURP are the surgical techniques mostly done in our setting. Hemorrhage, UTI and persistence of pollakiuria were the most common complications of BPH surgeries.
},
year = {2025}
}
TY - JOUR T1 - Sub-Saharan Aspects for the Benign Prostate Hypertrophy Postoperative Complications AU - Epoupa Ngalle Frantz Guy AU - Essomba Armel Quentin AU - Mbouché Landry Oriole AU - Mokam Fotso Victoire Thérèse AU - Mbassi Achille Aurel AU - Moby Mpah Hervé Edouard AU - Fouda Pierre Joseph Y1 - 2025/06/12 PY - 2025 N1 - https://doi.org/10.11648/j.ijcu.20250901.26 DO - 10.11648/j.ijcu.20250901.26 T2 - International Journal of Clinical Urology JF - International Journal of Clinical Urology JO - International Journal of Clinical Urology SP - 94 EP - 100 PB - Science Publishing Group SN - 2640-1355 UR - https://doi.org/10.11648/j.ijcu.20250901.26 AB - Background: Benign prostate hypertrophy (BPH) is mainly characterized by the increase in volume of the prostate gland. It is a frequently encountered pathology in current urological practice. The aim of the study was to evaluate various aspects of the management of postoperative complications, after BPH surgery, in a subsaharan nation. Methodology: This was a retrospective descriptive study carried out at the Douala General Hospital (DGH) and Douala Laquintinie Hospital (DLH) over a period of 5 years (January 1st 2016 to December 31st 2020). The results were compiled from (1st February to 31st May 2021) and data analysed using SPSS 25.0. The confidence interval was set at 95% where a p-value of less than 0.05 was considered statistically significant. Results: There were 151 cases in this study. The mean age was 72.3±11.8 years. Majority of the patients were within 60-69 years (27.83%). Pollakiuria, Nocturia and dysuria were the most common reasons of consultation. The medical management of BPH included alpha-blockers (55%), five alpha-reductase inhibitors (10.6%), phytotherapy (13.2%), and combination therapy (15.9%). With respect to surgical management open simple prostatectomy (OSP) was done in 65.6% of patients and Transurethral Resection of Prostate (TURP) in 34.4%. The rate of intraoperative complications was 15.9%, predominantly hemorrhage at 6.6%. Immediate and early complications acounted for 56% of complications with urinary tract infections making up the majority (22.5%). Late complications accounted for 28.8%. The incidence of intraoperative and late postoperative complications was associated with the type of surgery. This association was statistically significant with p-value of 0.013 and 0.030 for introperative and late complications respectively. The average duration of hospitalisation was 9.69± 3.053days. Conclusion: BPH is common in our setting among men older than 50 years. OSP and TURP are the surgical techniques mostly done in our setting. Hemorrhage, UTI and persistence of pollakiuria were the most common complications of BPH surgeries. VL - 9 IS - 1 ER -
Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon
Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon
Information